NCT00921661View on ClinicalTrials.gov

Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Colorectal NeoplasmsNeoplasm Metastasis
Interventions
DRUG

AVE0005 (aflibercept)

IV infusion

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Tokyo

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY

NCT00921661 - Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter